Analysis of ACE inhibitors in pharmaceutical dosage forms by derivative UV spectroscopy and liquid chromatography (HPLC).
Derivative UV spectroscopy and high performance liquid chromatography (HPLC) were applied to the determination of angiotensin-converting enzyme (ACE) inhibitors in their pharmaceutical dosage forms. For spectrophotometric determinations, the more appropriate derivative order was selected for each drug: ramipril (third-order), benazepril (second-order), enalapril maleate (second-order), lisinopril (first- and second-order) and quinapril (first-order). Reverse phase HPLC procedures (ODS column) were developed able to provide a single, symmetric peak for each drug; mixtures A-B, where A is 20 mM sodium heptansulphonate (pH 2.5) and B is acetonitrile-THF (95:5 v/v), proved to be suitable mobile phases to obtain selective separations of the cited ACE inhibitors. At ambient temperature, a low pH value (2.5) was found to be critical to avoid peak splitting and band broadening.
Bonazzi
D
D
Dipartimento di Scienze Farmaceutiche, Bologna, Italy.
Gotti
R
R
Andrisano
V
V
Cavrini
V
V
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000032:analysis*; D002138:Calibration; D002214:Capsules; D002851:Chromatography, High Pressure Liquid; D006863:Hydrogen-Ion Concentration; D013056:Spectrophotometry, Ultraviolet; D013607:Tablets
D000806:Angiotensin-Converting Enzyme Inhibitors; D002214:Capsules; D013607:Tablets